Bell Investment Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bell Investment Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21	Closed	-$807	–	2024
2023 Q2	$807	Buy	+21	New	+$539	﹤0.01%	1648

Bell Investment Advisors's KDNY Position: Q3 2023 in Review

Bell Investment Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 21 shares — an estimated $807 sold.

Bell Investment Advisors first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $807 in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Bell Investment Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bell Investment Advisors sold 21 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $807.
Bell Investment Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Bell Investment Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $807 in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bell Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.